Aureka Biotechnologies, Inc. logo — Inspire Therapeutic Design with Generative AI

Aureka Biotechnologies, Inc.

Inspire Therapeutic Design with Generative AI

Founded 2023 United States Laguna Hills, United States 33 employees Series A Total: $71.00M Biotechnology, Pharmaceutical

General Information

Company Name Aureka Biotechnologies, Inc.
Founded Year 2023
Location United States Laguna Hills, United States +1
Founders / Decision Makers
Team member
Employees 33
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when Aureka Biotechnologies, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aureka Biotechnologies, Inc.

Aureka Biotechnologies, Inc., founded in 2023, is a pioneering startup in the Biotechnology and Pharmaceutical industries, headquartered in the United States. Their slogan, "Inspire Therapeutic Design with Generative AI," encapsulates their mission to revolutionize drug discovery.

The company leverages cutting-edge technologies such as AI, microfluidics, and synthetic biology to democratize pharmaceutical development, principally focusing on immunotherapeutics. This integrated digital biology solution allows for an accelerated transition from concept to market, offering a significant competitive advantage in the drug discovery process.

Recently, Aureka Biotechnologies secured a substantial $35.00M Series A investment, attracting notable investors including Qiming Venture Partners, Matrix Partners China, 5Y Capital, Boyuan Capital, HongShan, and Newley Capital. This robust financial backing highlights strong investor confidence and positions the company advantageously for future growth in the biotech sector.

Taxonomy: Biotech Startup, Pharmaceutical Industry, Immunotherapeutic Discovery, Digital Biology, AI Solutions, Microfluidics, Synthetic Biology, Drug Discovery Platform, Immunotherapy, Deep Learning, BsAb Leads Optimization, Medicine Democratization, Integrated Biotechnologies

Services & Products

Discovery of high-value protein therapeutics
Rapid 'Generate-Test-Learn-Optimize' iteration cycles
Developing differentiated antibody therapeutics
High-throughput function-first design

Target Customers

Patients with cardiometabolic diseases Patients with inflammatory diseases Biotechnology and pharmaceutical companies

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor Investor
•••• ••••
01 Apr 2026
Series A •••••• 3
Investor Investor
•••• ••••
01 Nov 2025
Early VC •••••• 2
Investor Investor
01 Mar 2024
Seed •••••• 3 •••• •••• 01 Jun 2023
Spinout •••••• 1
Investor
01 Jan 2023

Aureka Biotechnologies, Inc. Alternatives & Competitors

View All Alternatives
Aureka Biotechnologies, Inc. vs
Cairn Biosciences
Cairn Biosciences United States

Navigating exclusive paths to new medicines

Grant
5 employees
Biotechnology, Health Care
Aureka Biotechnologies, Inc. vs
Nexo Therapeutics
Nexo Therapeutics United States

We’re driven to translate the most compelling and still undrugged targets in human biology into med...

Series A
19 employees
Biotechnology, Health and Wellness
Aureka Biotechnologies, Inc. vs
Coding Bio
Coding Bio United Kingdom

Building best-in-class cell therapies through automation & computation

Seed
22 employees
AI, Biotechnology

FAQ About Aureka Biotechnologies, Inc.

Inspire Therapeutic Design with Generative AI
Aureka Biotechnologies, Inc. was founded in 2023.
Aureka Biotechnologies, Inc. is headquartered in Laguna Hills, United States.
Aureka Biotechnologies, Inc. operates in the following industries: Biotechnology, Pharmaceutical.
Aureka Biotechnologies, Inc. has approximately 33 employees.
Aureka Biotechnologies, Inc. has completed 5 funding rounds, raising a total of $71.00M. The latest funding stage is Series A.
Aureka Biotechnologies, Inc. offers: Discovery of high-value protein therapeutics, Rapid 'Generate-Test-Learn-Optimize' iteration cycles, Developing differentiated antibody therapeutics, High-throughput function-first design.
Top alternatives and competitors to Aureka Biotechnologies, Inc. include Cairn Biosciences, Nexo Therapeutics, Coding Bio, NetTargets, (주)넷타겟, OPPILOTECH LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aureka Biotechnologies, Inc. and Cairn Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aureka Biotechnologies, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes